Viewing Study NCT00555061

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 1:04 PM
Ignite Modification Date: 2026-02-11 @ 6:57 AM
Study NCT ID: NCT00555061
Status: COMPLETED
Last Update Posted: 2016-12-28
First Post: 2007-11-06
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Pharmacokinetics of Retapamulin in Pediatric Subjects With Uncomplicated Skin Infections.
Sponsor: GlaxoSmithKline
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Skin Infections, Bacterial View
Keywords:

Keywords

Keyword Brief Keyword Text View
None SID View
None impetigo View
None pharmacokinetics View
None Retapamulin ointment, 1% View
None Skin abnormalities View
None Dermatoses View
None pediatric View
None infection View
None SITL View